Theophylline (Nuelin)
Theophylline
Inova Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Inova Pharmaceuticals (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Nuelin 125 MG EACH TABLET CONTAINS THEOPHYLLINE 125 mg | 125 mg | H0296H/10.2/296 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Theophylline
- and its derivatives, unless listed elsewhere in the Schedules, and preparations intended for injection. (S2)
Consolidated Schedules 06 July 2026, lines 8173 to 8174
S2: Theophylline
- and its derivatives, unless listed in another Schedule, and except in preparations for injection.
Consolidated Schedules 06 July 2026, line 2723
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
1,3-Dimethyl-7H-purine-2,6-dione
Drag to rotate. Structure from PubChem CID 2153.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.